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Medicinal plants are now recognized as most important alternative for chemical drugs resource, 
especially for anti-microbial targets. The current study aimed to determine the scolicidal effect of Allium 
paradoxium and Tanacetum parthenium as medicinal plants in vitro. Protoscoleces were exposed to 
different concentrations of chloroformic and hydroalcholic extracts (1, 10, 50 and 100 mg/mL) for 5, 10, 
30, 60 and 120 min. Viability of protoscolices was confirmed by 0.1% Eosin staining. The results of this 
study showed that all extracts used were not significantly effective in comparison with the control 
group. Therefore, chloroformic and hydroalcholic extracts of A. paradoxium and T. parthenium could 
not be used during hydatid cyst treatment. However, there remains the need to perform advanced 
comparative clinical studies on the efficacy of A. paradoxium and T. parthenium and other scolicidal 
agents. Chloroformic and hydroalcoholic extract of A. paradoxium and T. parthenium, did not show any 
scolicidal activity at the concentration of 1, 10, 50 and 100 mg/ml.  
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INTRODUCTION 
 
Hydatid disease due to Echinococcus granulosus remains 
an imperative, challenging medical problem (Brunetti et 
al., 2010). It is endemic in developing regions because of 
their poor socioeconomic conditions, but because of 
travelling and migration, it continues to have a global 
distribution. Hydatid cysts may be found anywhere in the 
body, but liver and lungs are the most infected organs 
(Pawlowski et al., 2001). Surgery is still the chosen 
method of treatment (Topcu et al., 2006). Repetition 
during the long-term follow-up period is the most usual 
problem with this therapeutic technique. For  decrease  in 
the recurrence rate of disease, it is necessary to avoid 
spilling of the cyst contents and the use of active 
scolicidal agents (Eckert et al., 2001). The World Health 
Organization (WHO) regards the use of both effective 
and safe agents for intraoperative killing of infectious 
material, but unfortunately; there is no ideal agent up to 
now. According to WHO reports, therapeutic plants with a 
relatively low risk are the suggested for traditional 
treatment of disease (WHO, 1996). 
Allium paradoxium and Tanacetum partheniumon are 
the Iranian native plants that indicate antimicrobial,
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Figure 1. The effects of chloroformic extract of A. paradoxium on viability of protoscoleces of hydatid cyst in 
concentration of 1, 10, 50 and 100 mg/ml after 5, 10, 30, 60 and 180 min in comparison with the control 
group. 
 
 
 
antifungal and antiviral effects. Also, these two plants 
showed antigiardial effects in vitro (Shirzad et al., 2014). 
B-Pinene (6.45%), limonene (3.4%), Z-nerolidol (18.01%), 
spathulenol (22.06%), alpha-bisabolol (5.06%), phytol 
(9.15%), n-docosane (4.79%) and n-tricosane (3.8%) are 
the most important identified compounds of A. 
paradoxium (Akbar and Ahmadi, 2010). Camphor and 
chrysanthenyl acetate are the main components of flower 
heads of T. parthenium (Mostafa et al., 2007). 
Considering the low range of scolicidal compounds, 
searching for a new scolicidal agents, particularly from 
natural sources is of great interest (Rahimi-Esboei et al., 
2012; Gholami et al., 2013).  
Since A. paradoxium and T. partheniumon has been 
shown to have a number of medicinal and anti-parasitic 
properties and considering the origin of these plants to 
Iran, the present study aimed to assess the scolicidal 
effect of the chloroformic and hydroalcholic extracts at 
different concentrations and for various exposure times. 
 
 
MATERIALS AND METHODS 
 
Parasite 
 
Hydatid cysts of E. granulosus were detached from livers of naturally 
infected sheep slaughtered at Mazandaran abattoir, northern part of 
Iran under aseptic conditions. The fluid of hydatid cyst containing 
protoscoleces was removed by a 50 ml syringe and transferred into 
a 50 ml Falcon tube. After 30 min of immovability, settled 
protoscoleces were washed three times with normal saline (pH 7.2). 
The viability of the parasites was assessed with 0.1% eosin under a 
light microscope (400x) (Gholami et al., 2013). 
 
 
Preparation of extracts 
 
The sliced seeds of A. paradoxium and the aerial parts of T. 
parthenium were dried under shade and powdered mechanically 
using a commercial electric blender. Dried powder (100 g) were 
extracted by percolation  method  with  hydroalchol  and  chloroform 
solution, separately for 72 h in room temperature. The obtained 
solution was passed through filter paper (Whatman No.3, Sigma, 
Germany) to remove plant debris. Finally, the extracts were 
concentrated using a rotary evaporator (Heidolph, Germany), 
placed in a sterile glass and stored at -4°C for later use (Shirzad et 
al., 2014). 
 
 
Scolicidal tests 
 
The scolicidal tests were done three times (triplicate) and based on 
Rahimi-Esboei et al. (2013). In the current study, four concentrations 
(1, 10, 50 and 100 mg/ml) of extracts were examined for 5, 10, 30, 
60 and 180 min. 2 ml of each concentration was transferred to a 
test tube; 50 µl of sediment protoscoleces was added to the tube 
and mixed lightly. The tube was then incubated at 37°C for 5, 10, 
30, 60 and 180 min. At the end of each incubation time, viability of 
the protoscoleces was evaluated by 0.1% eosin stain (Rahimi-
Esboei et al., 2013). 
 
 
RESULTS 
 
Results of the effectiveness of different concentrations of 
A. paradoxium and T. parthenium extract as a scolicidal 
agent are shown in Figures 1 to 4. While the viability rate 
in the control group was 88% after 180 min, scolicidal 
activity of chloroformic extract of A. paradoxium extract at 
concentration of 100 mg/mL was 90, 81, 78, 74 and 71% 
after 5, 10, 30, 60 and 180 min of application, respectively 
(Figure 1). Scolicidal effect of hydroalcholic extract of A. 
paradoxium extract at concentration of 100 mg/mL was 
88, 84, 79, 76 and 72% after 5, 10, 30, 60 and 120 min of 
exposure, respectively (Figure 2). While the viability rate 
in the control group was 85% after 180 min, scolicidal 
activity of chloroformic extract of T. parthenium extract at 
concentration of 100 mg/mL was 87, 85, 85, 81 and 78% 
after 5, 10, 30, 60 and 180 min of application, respectively 
(Figure 1).  
Scolicidal effect of hydroalcholic extract of T. 
parthenium extract  at  concentration  of  100 mg/mL  was  
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Figure 2. The effects of hydroalcholic extract of A. paradoxium on viability of protoscoleces of hydatid 
cyst in concentration of 1, 10, 50 and 100 mg/ml after 5, 10, 30, 60 and 180 min in comparison with the 
control group. 
 
 
 
 
 
Figure 3. The effects of chloroformic extract of T. parthenium on viability of protoscoleces of hydatid cyst in 
concentration of 1, 10, 50 and 100 mg/ml after 5, 10, 30, 60 and 180 min in comparison with the control group. 
 
 
 
84, 78, 78, 73 and 69% after 10, 20, 30 and 40 min of 
exposure, respectively (Figure 2). 
In this study, the effectiveness of two plants were 
increased by increasing the time and concentration of 
plants, but there was no significant differences between 
times of exposure and concentration of extracts.  
 
 
DISCUSSION 
 
The current work examined the scolicidal activity of A. 
paradoxium and T. parthenium using the chloroformic 
and hydroalcholic extracts and an in vitro technique. 
Shirzad et al. (2014) showed high effectiveness of A. 
paradoxium and T. parthenium on Giardia lamblia in in 
vitro investigation with concentration of 100 mg/ml after 3 
h. Also, this antigiardial activity of A. paradoxium was 
reproved by Elmi et al. (2014) in an in vivo study. Despite 
the anti-bacterial and anti-parasitic activity of these 
plants, the results of this study indicate insignificant 
efficacy against protoscoleces of hydatid cyst (Shirzad  et 
al., 2014). It could be concluded that protoscoleces of 
hydatid cyst are more resistance than other used 
microorganisms and it depends on the physiological 
stricture of cells. In this study, the used plants were 
inactive against protoscoleces of hydatid cyst. Perhaps, a 
longer exposition time was needed while the same 
concentration and exposure time was effective against 
some microbial and parasitic infections (Sarkari et al., 
2009; Mehrabi et al., 2011; Radwan et al., 2012). 
This in vitro technique is simple but confirmed, 
trustworthy, sensitive and extensively used (Dey, 1980). 
Therefore, the results gained are permissible and 
reliable. As shown (Figures 1 to 4), the chloroformic and 
hydroalcholic extracts of A. paradoxium and T. 
parthenium did not exhibit any in vitro scolicidal activity, 
even at concentrations of 100 mg/ml after 180 min. From 
the extracts and plants, hydroalcholic extract of T. 
parthenium was the most effective extract in concentration 
of 100 mg/ml after 180 min. 
This study strongly recommends evaluating the activity 
with a longer period and develops more research  on  the
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Figure 4. The effects of hydroalcholic extract of T. parthenium on viability of protoscoleces of hydatid 
cyst in concentration of 1, 10, 50 and 100 mg/ml after 5, 10, 30, 60 and 180 min in comparison with the 
control group. 
 
 
 
phytochemistry of these plants. 
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Control of leishmaniasis remains a challenge due the high toxicity of the chemotherapeutic drugs 
presently available. The ongoing search for better leishmanicidal compounds has brought herbal drugs 
into the limelight as safe and effective substitutes to conventional therapies which have various 
drawbacks. The current study was designed to evaluate the antileishmanial effect of Quassia amara 
against Leishmania amazonensis and Leishmania infantum. Different fractions (Hexane (Q1), 
dichloromethane (Q2), ethyl acetate (Q3) and butanol (Q4)) obtained from the liquid-liquid partition of 
the crude Q. amara methanol extract were tested against Leishmania promastigote forms. After 120 h of 
treatment with Q. amara fractions (1 to 500 µg/ml), the minimal inhibitory concentration (MIC) was 
determined using resazurin. The most active fraction (Q2) was analyzed using thin layer 
chromatography (TLC) and high performance liquid chromatography-diode array detector (HPLC-DAD) 
techniques. The effects of Q2 on parasite ultrastructure were investigated by transmission electron 
microscopy. In addition, Leishmania-infected macrophages were treated with Q2 in order to evaluate 
the anti-amastigote effect. Among the fractions tested, Q2 showed the highest activity against L. 
amazonensis and L. infantum promastigotes MIC values of 62.5 and 31.25 µg/ml, respectively. There 
were ultrastructural alterations, such as nuclear chromatin condensation, intense vacuolization and 
autophagic and myelin-like figures in parasites treated with Q2 (62.5 µg/ml). Macrophages previously 
infected with L. amazonensis and L. infantum promastigotes showed a drastic reduction in the number 
of parasites recovered in the supernatant after Q2 treatment at MIC values. The TLC and HPLC 
fingerprints of Q2 showed that alkaloids were the main chemical constituents in this fraction. The 
results presented herein showed that the alkaloid-rich fraction Q2 is a promising source of 
antileishmanial agents. Further investigation will be necessary in order to isolate and test the 
substance(s) responsible for the bioactivity. 
 
Key words: Antileishmanial activity, Quassia genus, alkaloids, macrophage infection, nitric oxide.  
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INTRODUCTION 
 
Leishmaniasis is a group of illnesses caused by several 
species of protozoa belonging to the Leishmania genus. 
They are considered endemic in 98 countries and have a 
broad spectrum of clinical manifestations ranging from 
disfiguring skin lesions, known as tegumentary 
leishmaniasis (TL) to the visceral form of the disease, 
visceral leishmaniasis (VL) or kala-azar, that can lead to 
death (Hartley  et al., 2012; Rebbestad et al., 2012). 
Brazil possesses the highest incidence of TL and VL with 
26,008 and 3,481 cases reported, respectively (Roqueline 
et al., 2014). The dissemination of the disease may occur 
by human to-human transmission (anthroponotic 
transmission) or from animals to humans (zoonotic 
transmission). In both cases, parasites (infective 
metacyclic promastigote forms) are transmitted during the 
insect vector hematophagy (Chakravarty and Sundar, 
2010). Once inoculated in the dermis-epidermis junction 
of the vertebrate hosts, infective parasites are phago-
cytized by macrophages and then initiate the 
differentiation process to amastigotes, the evolutive form 
responsible for the disease establishment and 
progression (De Pablos et al., 2016). Since macrophages 
play a pivotal role in the infection as host cells, the search 
for drugs able to elicit an effective antileishmanial 
response by these cells becomes essential.     
Pentavalent antimony compounds and amphotericin B 
are the main drugs prescribed for the treatment of 
leishmaniasis. In addition, other drugs can be used such 
as pentamidine and paromomycin, which are more 
effective against the tegumentary form of the disease and 
miltefosine, the orally active drug indicated for VL 
treatment (Sundar and Singh, 2016; Dorlo et al., 2012; 
Frézard et al., 2009; Jhingran et al., 2009). However, 
these drugs present variable efficacies and high toxicity 
(e.g. cardiotoxicity, hepatotoxicity and nephrotoxicity), 
which may lead to diverse side effects. The development 
of parasite drug resistance is an additional problem for 
the control of leishmaniasis (Sundar and Chakravarty, 
2015). In this scenario, several research laboratories 
around the world have been focused on the prospection 
of plant species as a strategy for discovery of more 
effective substances against leishmaniasis.     
Quassia amara L. (Simaroubaceae) is a tree species 
found in tropical regions including Central and South 
America, where it is popularly known as “pau-tenente”, 
“amargo”, “grande hombre” or “quassia”. The tree can 
reach 8 m in height featuring compound leaves, red 
flower petals and drupes about 1 to 2 cm long. Several 
extracts obtained from the leaves, bark or wood of Q. 
amara have traditionally been used  as  natural  remedies  
 
 
 
 
for the treatment of digestive and liver disorders, and 
malaria (López and Pérez, 2008). In fact, the Quassia 
genus is a known source of biologically active extracts 
against protozoa. The aqueous extract of Quassia 
africana root bark displayed antitrypanosomal, anti-
plasmodial and antileishmanial activities in concentrations 
ranging from 0.46 to 5.94 µg/ml (IC50 values) (Musuyu 
Muganza et al., 2012). Some authors have described the 
antimalarial activity of Q. amara species. Ajaiyeoba et al. 
(1999) demonstrated that the methanol extract of Q. 
amara leaf displayed strong antimalarial activity in a 
murine model. Further investigations revealed that 
quassinoids such as simalikalactone D, simalikalactone 
E, quassin and neoquassin were responsible for the 
antimalarial properties (Mishra et al., 2010; Cachet et al., 
2009; Bertani et al., 2006). The present work investigates 
the antileishmanial potential of an alkaloid-rich fraction 
obtained from Q. amara. 
 
 
MATERIALS AND METHODS 
 
Plant and extraction procedures    
 
Q. amara stem bark was commercially obtained in a popular street 
market located in Aracaju (Sergipe, Brazil). Samples were 
authenticated by Dr. Rosana C. Lopes at the RFA Herbarium, 
Department of Botany, Federal University of Rio de Janeiro 
(IB/UFRJ), where a voucher specimen is deposited (RFA 40769). 
The samples (315 g) were extracted for 5 days at room temperature 
using methanol (1 L). Then, the methanol extract was dried (yield 
=1.23%), resuspended in 150 ml of distillated water, and subjected 
to solvent partitioning (1:1) in the following order: hexane, 
dichloromethane, ethyl acetate and butanol. After the evaporation 
of the solvents Q1 (yield =20.5%), Q2 (yield =16.6%), Q3 (yield 
=2.96%) and Q4 (yield =0.87%) fractions were obtained, 
respectively, and kept in amber flasks at 4°C until biological and 
chromatographic analysis.      
 
 
Thin layer chromatography (TLC) analysis 
 
TLC was performed using TLC Silica gel plates (Merck), 0.25 mm; 
eluent system: 2% methanol/dichloromethane; detection: 
Dragendorff and sulfuric acid spray reagents. After spraying the 
plates were visually analyzed. 
 
 
Q2 fraction analysis by fast high performance liquid 
chromatography-diode array detector (HPLC-DAD)  
 
Liquid chromatography was performed using a Shimadzu fast 
HPLC-DAD. The sample was applied using an automatic injector 
and separated on a Kinetex C18 column, 150 mm × 4.6 mm, 2.6 
µm at 35°C. The mobile phase was a gradient of solvent A (H2O 
with  0.1%  of  formic acid) and B (acetonitrile) from 3 to 25% of B, 0 
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to 12 min and from 25 to 75% of B, 12 to 22 min. The acetonitrile 
used was HPLC grade (Tedia) and the water was purified with a 
Milli-Q system. Q2 (2.0 mg) was dissolved in 1.0 ml of water and 
then centrifuged for 10 min prior the analysis. The flow and sample 
injection volume were 1 ml/min and 2.0 µl, respectively. The 
chromatogram was acquired at a wavelength of 275 nm.  
 
 
Parasites tested 
 
Leishmania amazonensis (IFLA /BR/1967/PH8) and Leishmania 
infantum (MHOM/BR/1974/PP75) promastigotes were donated by 
the Leishmania Type Culture Collection of Oswaldo Cruz 
Institute/Fiocruz (Rio de Janeiro/RJ/Brazil). Parasites were 
axenically cultured in PBHIL medium supplemented with 10% fetal 
bovine serum (Rodrigues et al., 2010). 
 
 
Leishmania inhibitory assay 
 
In order to evaluate the antileishmanial activity of Q. amara 
extracts, L. infantum and L. amazonensis promastigote forms were 
harvest at early stationary phase (96 h), washed twice with PBS 
(150 mM NaCl; 20 mM phosphate buffer, pH 7.2) and re-suspended 
in fresh culture medium at a concentrations of 107 parasites/ml.  
Then, 100 µl of the cellular suspension was added to 96-well 
microplates, where Q. amara fractions had been previously diluted 
(final concentrations ranging from 0.97 to 500 μg/ml). The 
microplates were incubated at 28°C for 24, 48 and 120 h.  Parasite 
growth was evaluated daily by direct counting of the cells in a 
Neubauer chamber. The minimum inhibitory concentration (MIC) 
was determined using resazurin as the cellular viability indicator 
(Rolon et al., 2006). Amphotericin B was used as positive control. 
Alternatively, cultures presenting negative parasite growth were re-
incubated in fresh culture media aiming to evaluate a leishmanicidal 
or leishmanistatic effect. 
 
 
Ultrastructure analysis 
 
L. amazonensis promastigote forms were harvested at early 
stationary phase and treated with Q2 fraction at inhibitory (MIC) and 
sub-inhibitory (MIC/2) concentrations for 24 h at 28°C. After the 
incubation period, the parasites were washed twice with PBS and 
then fixed in 0.9% glutaraldehyde solution (2.5% glutaraldehyde in 
0.1 M sodium cacodylate buffer containing 3.5% sucrose, pH 7.4) at 
4°C for 60 min. The samples were sent to the Rudolf Barth Platform 
(IOC/FIOCRUZ/RJ) and processed as previously described 
(Rodrigues et al., 2013). Image acquisition was made with a JEOL 
JEM1011 transmission electron microscope. 
 
 
Cytotoxic evaluation 
 
Peritoneal macrophages were obtained as previously described 
(Rodrigues et al., 2013). The maintenance procedures and 
euthanasia of animals were approved by the UFRJ Committee of 
Ethics for the Use of Animals (license 154/13). Macrophages 
(2.5×105 cells) were allowed to adhere into 96-well microplates for 
20 min at 37°C and 5% CO2 atmosphere. The macrophage cultures 
were washed with PBS and incubated in the presence of Q. amara 
Q2 fraction at concentrations ranging from 0.97 to 500 μg/ml for 24 
and 48 h. The cellular viability of Q2-treated macrophages was 
evaluated by resazurin reduction assay as previously described (Al-
Musayeib et al., 2012). 
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Macrophage infection and nitric oxide production 
 
The infection assays were performed following the protocol 
previously described by Passero et al. (2010) with slight 
modifications. Briefly, peritoneal macrophages (1.0 × 106 cells/ml) 
were distributed in 96-well microplates. Subsequently, pro-
mastigotes forms of L. amazonensis or L. infantum were added (5 
parasites per macrophage). The parasite-macrophage interaction 
was performed in RPMI 1640 medium supplemented with 10% FBS 
at 37°C and 5% CO2 atmosphere for 24 h. After the incubation 
period, free promastigotes were removed by extensive washing with 
PBS and then the cultures were treated with Q2 at 31.25 and 15.62 
µg/ml, MIC and subMIC, respectively. After 48 h of treatment, 
culture supernatants were collected for nitric oxide determination 
(Green et al., 1990). The infected macrophages were washed and 
re-incubated with PBHIL supplemented with 10% FBS for 72 h at 
28°C in order to evaluate the number of promastigotes that 
recovered. The experiment was performed in triplicate and the 
number of viable promastigotes was determined by the average of 
cell counts using a Neubauer chamber. 
 
 
Statistical analysis of the data 
 
The mean and standard error of at least three experiments were 
determined. Statistical analysis of the differences between mean 
values obtained for experimental groups was done by means of 
Student’s t-test. P values of 0.05 or less were considered significant. 
 
 
RESULTS 
 
Parasite growth inhibition 
 
Among the four fractions, Q2, Q3 and Q4 displayed 
antileishmanial activity against L. amazonensis and L. 
infantum promastigotes with MIC values ranging from 
31.25 to 500 µg/ml (Table 1). Q1 was not active against 
the promastigotes at the highest concentration tested 
(MIC > 500 µg/ml). Q2 presented the best results and 
was able to terminate L. amazonensis and L. infantum 
growth at 31.25 and 62.5 µg/ml, respectively. Moreover, 
Q2 exerted an inhibitory effect on Leishmania growth at 
the sub-inhibitory concentrations (subMIC) of 15.62 and 
31.25 µg/mL for L. amazonensis and L. infantum, 
respectively (Figure 1A and 1B). Based on these results 
the researcher decided that all further experiments would 
be only with the Q2 fraction. 
 
 
Ultrastructural alterations 
 
Ultrastructural alterations in Q2-treated L. amazonensis 
promastigotes were investigated using TEM. Figure 2A 
and B shows control parasites displaying normal 
morphology and intracellular organelles. After 24 h 
exposure to 62.5 µg/ml of Q2 (MIC value), significant 
alterations were observed in the parasites, such as 
electron dense granules and myelin-like figures in the 
cytoplasm (Figure C). In addition, parasites showed 
mitochondrial dilatation with concentric membranes in the 
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Figure 1. Antiproliferative effect of Q2 on L. amazonensis (A) 
and L. infantum (B) promastigotes. Parasites were counted at 
24-h intervals using a Neubauer chamber. Each bar represents 
the mean ± standard error of at least three independent 
experiments, which were performed in duplicate. The asterisks 
(*) indicate a significantly different value from the untreated 
parasites (p < 0.05). 
 
 
 
mitochondrial matrix, nuclear chromatin condensation 
and the presence of autophagic structures (Figure 2E). 
Vesicles with cytoplasmic content released from the cell 
body into the flagellar pocket were also noted (Figure 
2D).  
 
 
Cytotoxicity for peritoneal macrophages 
 
The effect of Q. amara Q2 fraction on peritoneal 
macrophages was investigated (Table 1). Q2 displayed 
toxic effect at 500 µg/ml (minimal cytotoxic concentration 
- MCC); allowing its use at effective concentrations 
against L. amazonensis and L. infantum. 
 
 
Anti-amastigote activity 
 
In order to evaluate the effects of Q2 in vitro, peritoneal 
macrophages were previously infected with L. 
amazonensis   or   L.   infantum  promastigotes  and  then 
treated with Q2 at MIC and subMIC concentrations. After 
48 h of infection, Q2 was removed by washing and the 
cultures were reincubated under proper conditions for 
promastigote recovery. The results demonstrate that the 
number of promastigotes recovered in the treated macro-
phage culture supernatants was very low, regardless of 
the Q2 concentration tested (Table 2).  
In addition, the nitric oxide (NO) produced by the 
macrophages during the infection period was determined. 
The study showed that only L. amazonensis- and L. 
infantum-infected macrophages treated at MIC 
concentration of Q2 produced high amounts of NO when 
compared to their respective untreated cultures. Indeed, 
the NO production was about 159 and 183% higher than 
the untreated cultures, respectively.  
 
 
Chromatographic analysis of Q2 
 
Alkaloid-rich  fraction  (Q2)  was  detected  by   TLC   with 
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Table 1. Antileishmanial activity of the four fractions derived from the Q. amara methanol extract. 
 
Fractions  
Minimal inhibitory concentrations (µg/ml) 
L. amazonensis L. infantum 
24 h 48 h 120 h 24 h 48 h 120 h 
Q1 >500.0 >500.0 >500.0 >500.0 >500.0 >500.0 
Q2 62.5 62.5 31.25 125.0 62.5 62.5 
Q3 500.0 62.5 62.5 >500.0 250.0 250.0 
Q4 250.0 125.0 125.0 >500.0 500 500 
AmphB 1.95 0.97 0.97 0.97 0.48 0.48 
 
Q1: Q. amara hexane fraction; Q2: Q. amara dichloromethane fraction; Q3: Q. amara ethyl acetate fraction; 
Q4: Q. amara butanol fraction; AmphB: Amphotericin B. 
 
 
 
Table 2. Effects of Q2 on L. amazonensis and L. infantum intracellular amastigotes and nitric oxide 
production by infected macrophages. 
 
Q2 treatment 
Promastigote recovery (×10
4
 cells/mL) NO2 (µM) 
La (±SE) Li (±SE) SLa (±SE) SLi (±SE) 
Control 46.0 (±2.55) 33.0 (±6.33) 2.03 (±0.3) 6.23 (±2.0) 
MIC 0.01 (±5.47) 0.04 (±0.03) 5.75 (±0.3) 16.2 (±3.3) 
SubMIC 0.01 (±3.92) 0.17 (±0.1) 3.14 (±0.8) 6.37 (±3.0) 
 
La: Leishmania amazonensis; Li: Leishmania infantum; SLa: Supernatant of L. amazonensis-infected cultures; SLi: 
Supernatant of L. infantum-infected cultures; MIC: minimum inhibitory activity; SubMIC: sub-inhibitory 
concentration. MIC and subMIC values for L. amazonensis were 31.25 and 15.62 𝜇g/ml, respectively. MIC and 
subMIC values for L. infantum were 62.5 and 31.25 𝜇g/ml, respectively. 
 
 
 
 
 
Figure 2. Photomicrographs of L. amazonensis promastigotes treated with Q2 fraction. (A-B) 
Control. (B) Flagellar pocket and mitochondrion containing the kinetoplast. (C-F) MIC-treated 
parasites. (C) Nuclear chromatin condensation, electron dense bodies (*) and myelin-like 
figures (). (D) Dilated flagellar pocket containing vacuoles () and a multi vesicular 
structure (). (E) Mitochondrial swelling and a vesicle () inside this organelle. (F) Intense 
vacuolization process and an autophagic structure (*). n, nucleous; m, mitochondrion; k, 
kinetoplast; f, flagellum; fp, flagellar pocket; L, lipid. 
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Figure 3. HPLC-DAD chromatogram of Q2 and UV spectrum of the main alkaloid. 
 
 
 
characteristic orange color after revelation with 
Dragendorff reagent. The spots on TLC plates did not 
show red coloration when sprayed with sulfuric acid 
reagent which indicates the probable absence of 
quassinoids (Polonsky et al., 1980). The chemical 
fingerprint obtained by the HPLC-DAD analysis confirmed 
the presence of this class of substances, showing their 
characteristic UV spectra (Figure 3). 
 
 
DISCUSSION 
 
Plants represent a promising source of medicinal 
substances that are biologically active against several 
pathogens, including Leishmania. Sarkar et al. (2013) 
reported that the antileishmanial activity of the petroleum 
ether, chloroform and methanol extracts obtained from 
the leaves of Pleumeria pudica. In that study, all the 
extracts had strong activity against the Leishmania 
donovani promastigote forms with IC50 values ranging 
from 2.93 to 3.04 µg/ml. Triterpenoids were the main 
substances found in the extracts and may be responsible 
for the bioactivity (Sarkar et al., 2013). The crude 
methanol extract of Lantana ukambensis leaves was also 
active against L. donovani with IC50 value at 6.9 µg/ml 
(Sawadogo et al., 2012a). Tannins, triterpenes, and 
steroids were previously reported by these authors as the 
main substances of the extract (Sawadogo et al., 2012b). 
Bhattacharjee et al. (2009) studied the effect of the 
quassinoid quassin isolated from Q. amara as 
immunomodulator for controlling the establishment of L. 
donovani infection. The use of Q. amara against different 
infectious diseases (Mans et al., 2016; Bertani et al., 
2006; Ajaiyeoba et al., 1999) encouraged us to investigate 
the antileishmanial potential of this species against L. 
amazonensis and L. infantum.  
Using the bioguided approach, the study reported that 
Q2 (dichloromethane fraction of the crude methanol 
extract) was the most active fraction against both 
parasites after treatment for 120 h. Table 1 shows that 
the antileishmanial activity of the extracts, including Q2, 
is time- and dose-dependent. Other species belonging  to 
the Simaroubaceae family have been described as 
biologically active against several pathogens in a time 
and dose dependent manner. Gu et al. (2014) reported 
that the ethanol extract from Ailanthus altissima 
increased Psoroptes cuniculi and Sarcoptes scabiei 
mortality with increasing both extract concentration and 
post-treatment time. In the present study, MIC values 
decreased in one fold dilution when parasites were 
treated for 120h. Parasite killing was confirmed after 
reincubation of inhibited cultures in fresh medium and no 
growth was detected. In addition, Figure 1 shows that L. 
amazonensis promastigote growth was strongly inhibited 
by Q2 in the first 72 h of treatment even at the sub-
inhibitory concentration of 15.62 µg/mL. The complete 
elimination of the parasites occurred after 96 h of 
treatment at 31.25 µg/ml. On the other hand, the growth 
of L. infantum promastigotes was inhibited by all Q2 
concentrations tested until 96 h of treatment when 
compared with control cells. However, parasites regained 
growth after this period except those treated at 
concentrations above 62.5 µg/ml. In order to determine if 
Q2 displays leishmanicidal activity, the L. amazonensis 
and L. infantum promastigote forms treated with MIC 
values (31.25 and 62.5 µg/mL, respectively) were re-
introduced into fresh culture  medium (in the absence of 
Q2). We observed that those cultures were no longer 
able to grow, showing strong evidence that Q2 displayed 
a leishmanicidal effect.  
Q2 caused serious damages to the L. amazonensis 
promastigote forms. Mitochondrial swelling, the presence 
of myelin-like figures and autophagosomal structures on 
cytoplasm suggested disturbances of the sterol 
biosynthesis (Figure 2). This study is in line with other 
study report when using known or novel synthetic 
ergosterol synthesis inhibitors to treat Leishmania (de 
Macedo-Silva et al., 2015; de Macedo-Silva et al., 2013; 
Zeiman et al., 2008). Plant-derived products, extracts or 
isolated substances can inhibit Leishmania sterol 
biosynthesis. Previously, our group reported that a 
fraction (B2) obtained from the hexane extract of 
Arrabidaea chica caused similar damages to L. infantum 
promastigotes  (Rodrigues  et  al., 2014). L. amazonensis  
 
 
 
 
treatment with 1 to 5 µM tomatidine, a tomato alkaloid, 
led to the inhibition of Δ24(25)-sterol methyltransferase, 
an essential enzyme for the ergosterol production 
(Medina et al., 2012). 
Several studies have shown that alkaloids, flavonoids, 
chalcones, terpenoids, saponins, and phenolic compounds 
display antileishmanial effect (Sandjo et al., 2016; Singh 
et al., 2014; Wink, 2012). In the present study, HPLC-
DAD was employed to evaluate the phytochemical profile 
of Q2. This technique is able to define the chemical 
classes of substances from natural origins based on their 
characteristic UV spectrum (Escarpa and Gonzalez, 
1998; Justesen et al., 1998). The principal substances of 
Q2 detected by TLC presented orange spots after 
chemical revelation with Dragendorff reagent and 
HPLC/DAD demonstrated the UV spectra that indicate 
alkaloid class (Figure 3).  There are few studies on the 
alkaloid content of Q. amara, which includes indole and 
canthin-6-one alkaloids (Barbetti et al., 1987; Barbetti et 
al., 1990; Njar et al., 1993). In fact, the investigation of 
the pharmacological potential of Q. amara-isolated 
alkaloids has been neglected, since quassinoids have 
been described as the main biologically active agents in 
this species. In this study, Q2 fraction rich in alkaloids 
displayed minimum cytotoxic concentration against 
peritoneal macrophages at 500 µg/ml. In addition, Q2 
reduced the number of parasites recovered on L. 
amazonensis- and L. infantum-infected macrophages 
cultures at MIC concentrations, with a concomitant 
increase of NO production of about 2.8 and 2.6 fold 
higher than the controls, respectively (Table 2). Recently, 
Mans et al. (2016) reported the antileishmanial activity of 
25 Surinamese medicinal plants traditionally used to treat 
cutaneous leishmaniasis, including Q. amara. The 
authors observed that the Q. amara aqueous extract was 
able to inhibit L. major NADIM5 and L. donovani GEDII 
promastigotes growth (IC50 values of 51 and 68 µg/ml, 
respectively). However, the aqueous extract of Q. amara 
was extremely toxic for THP-1 cells (IC50 < 16 µg/ml). 
They also observed that the aqueous extract reduced in 
50% the number of intracellular amastigotes at 288 
µg/ml. These data is controversial since cytotoxic 
concentrations were used in the infection assay. In the 
present study, infected macrophages were treated with 
parasite subinhibitory concentrations, allowing us to 
evaluate the treatment effect over internalized parasites 
without macrophage damage.  Nevertheless, the study 
cannot assure that the obtained results were caused by 
the alkaloid content of Q2. Studies in our laboratory are in 
progress in order to fractionate Q2 and evaluate the 
antileishmanial activity of the isolated substances. 
 
 
Conclusion 
 
Our results demonstrated the antileishmanial properties 
of Q. amara against the etiological agents of tegumentary 
and   visceral    leishmaniasis,   L.   amazonensis  and  L.   
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infantum, respectively. Despite the quassinoids bioactivity 
described in the literature, the study showed that an 
alkaloid-rich fraction (Q2) obtained from Q. amara was 
the most active fraction against the parasites. This is an 
interesting finding due the relevance of alkaloids as 
potential therapeutic agents. The present study highlights 
Q. amara, a plant widely used in folk medicine, as a 
source of antileishmanial agents.  
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The in silico simulations and predictions approach in evaluation of pharmacokinetic properties of new 
chemical entities (NCEs) is fast becoming an acceptable trend in natural products research and drug 
discovery. This paper focuses on the properties of trolline with respect to its anti-inflammatory and 
MCF-7 breast cancer cell line growth inhibition effects and an attempt to predict physico-chemical drug-
like properties in silico. The compound was isolated for the first time from aerial parts of Mirabilis jalapa 
and the structure was elucidated by 1D and 2D NMR, FTIR and mass spectroscopic analyses. The 
compound was screened for anti-inflammatory and anti-MCF-7 cell lines proliferation using 
chemoluminiscence oxidative burst and MTT assays respectively. Predictions on physico-chemical 
properties central to oral route drug administration were done using commercial software Admet 
predictor. Results show anti-inflammatory effects at IC50 concentration of 53.8 µg/ml and 48% mortality 
of breast cancer cell lines at 50 µM concentration. Predictions suggest moderate solubility of 1.72 to 
2.92 mg/ml across pH range of 1.6 to 6.8 in simulated solvent systems and effective jejunal permeability 
of 5.61 x 10
-4
 cm/s. The compound was also predicted to be 60% unbound to plasma proteins and an 
LD50 of 950 mg/kg in rats. The compound, trolline had clinically important bioactive effects, probably 
possess promising drug-like properties suitable for further high throughput screening. 
 
Key words: ADMET, anti-inflammatory, in silico prediction, Mirabilis jalapa, NMR, trolline. 
 
 
INTRODUCTION  
 
The search for new chemical entities (NCEs) has 
prompted the resurgence in isolation and screening of 
natural products from diverse sources. Although, the last 
decade experienced a decline  in  the  interest  in  natural 
products research, this has not necessarily resulted in 
increase in NCEs approved as drugs through 
combinatorial chemistry aided synthesis (Harvey, 2008). 
So far, the best-selling therapeutic drugs as  at  2012  are  
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natural products or derived from them (Newman and 
Cragg, 2012). Quite a number of medicinal plants and 
other sources of natural products like the actinomycetes 
have been identified and are currently researched for 
their potential as sources of lead candidates for NCEs 
that are of clinical importance. 
The plant, Mirabilis jalapa Linn. belongs to the 
Nyctagenaceae family, a perennial herbaceous plant that 
grows to a height of 50 to 100 cm. The seeds are 
wrinkled and turn black upon maturity while its beautiful 
flowers open around 4 O’ clock (Nair et al., 2005). The 
plant commonly called marvel of Peru in English is 
indigenous to South America and other tropical climates 
(Taylor, 2005). In Nigeria, it is locally known as Tonaposo 
in Yoruba language (Elufioye et al., 2012) while in 
Pakistan, it is called Gul-abbas (Dhar et al., 1968). 
Phytochemical investigation reveals the presence of β-
sitosterol, ursolic acid, amino acids, β-stigmasterol (Singh 
and Mittal, 2012), phytol (Siddiqui et al., 1994) in the 
aerial parts while rotenoids (Xu et al., 2010) and 
trigonelline (Zhou et al., 2012) alkaloid have been 
characterized from the roots. The plant is known to 
possess medicinal properties across different cultures. In 
Brazilian folk medicine for example, the leaf extract is 
used in treatment of inflammation (Walker et al., 2008). 
Extracts of the aerial parts are also used as purgative 
and in the treatment of dysentery (Encarnacion et al., 
1998) and diarrhea (Holdsworth, 1992; Comerford, 1996). 
In Chinese traditional medicine, the root of this plant is 
used as an anti-diabetic (Zhou et al., 2012). Several 
literature reports on scientific studies on various parts of 
the plant suggest the presence of clinically important 
pharmacologic properties (as claimed), including 
antibacterial (Eneji et al., 2011), anti-viral (Wong et al., 
1992), anti-inflammatory (Nath et al., 2010) and treatment 
for dysentery (Shaik et al., 2012). Importantly, bioguided 
isolation of small molecules from M. jalapa have also 
been demonstrated to have clinically important properties 
including trigonelline (Zhou et al., 2012) and boravinone 
rotenoids (Xu et al., 2010) isolated from the roots of this 
plant were shown to have anti-diabetic and in vitro anti-
cancer activities, respectively.  
The cost of bringing a new drug into the market usually 
requires heavy budgetary commitments from 
pharmaceutical industries. Indeed many lead compounds 
have either been rejected or fail completely at advanced 
stages of clinical trials. More complicating is the 
withdrawal of otherwise approved drugs from the market 
due to evidences emerging from pharmacovigilance 
(McNaughton et al., 2014; Onakpoya et al., 2015). 
Developments in in silico simulations and predictions 
using reliable data obtained from laboratory experiments 
have proven to provide the platform for the advancement 
of research in screening and testing of NCEs (Yu and 
Adedoyin, 2003; Moroy et al., 2012) as a viable 
alternative to circumvent these problems that result in 
huge   investments   go   down   the   drain.    There    are  
 
 
 
 
commercially available softwares (Boobis et al., 2002) 
that predict and simulate the fate of drug components as 
they interact with different compartments of the body 
notably, the administration, distribution, metabolism, 
elimination and toxic (ADMETox) outcomes of NCEs. In 
silico models built around the quantitative structure 
activity relationship (QSAR) concepts for example, have 
helped describe physicochemical properties of molecules 
by reliable laboratory data parameterization and 
development of molecular descriptors (Butina et al., 
2002). 
A careful study of reported activities of M. jalapa 
suggest constituents of polar fractions of the various plant 
parts may contain substances responsible for observed 
activities (Muthumani et al., 2010; Nath et al., 2010; 
Oladunmoye, 2012). The isolation of 8,9-dihydroxy-
1,5,6,10b-tetrahydropyrrolo[2,1-a]isoquinolin-3(2H)-one 
(trolline) from polar fractions of aerial parts of M. jalapa is 
reported. This compound was previously isolated from 
the plants Salsola collina Pall (Zhao and Ding, 2004) and 
Trollius chinensis (Li-Jia et al., 2014). The following study 
seeks to investigate possible anti-inflammatory properties 
and the ability of this compound to inhibit growth of MCF-
7 breast cancer cell lines in vitro. the physicochemical 
drug-like properties of this compound were also 
evaluated by in silico predictions.  
 
 
MATERIALS AND METHODS 
 
Aerial parts of M. jalapa L. plant was collected from the National 
Veterinary Research Institute (NVRI) Vom, Plateau State Nigeria. A 
voucher number 2441 was deposited having been identified at the 
herbarium section of the Biological Science Department, Ahmadu 
Bello University Zaria, Nigeria. The plant parts were air dried under 
shade and then crushed using pestle and mortar. The coarse 
particles size material was then immediately extracted using 
organic solvent.  
 
 
Plant extraction and chromatography 
 
Methanol was used to extract 29 g of pulverized plant parts after 
which hydrated butanol was used to re-extract by partitioning. 
Fractions F50-F80 obtained from silica column (mesh size 60-120) 
eluted with 10% MeOH : DCM were pulled together and further 
separated on flash column, 40% acetone : hexane elution. 
Fractions F33-F45 from this column were pulled and separated on 
MCI-gel column eluted with 60% H2O : MeOH to obtain F23. The 
fraction F23 was further purified using recycling HPLC (JAI, RP 
column ODS H-80) at a flow rate of 2.5 ml/min to obtain 12 mg of 
the pure compound. The sonicated HPLC grade isocratic solvent 
system used was 60% H2O : MeOH.  
 
 
Spectroscopic data 
 
IR (3425, 2925, 1649, 1527, 1452cm-1); 1H NMR (600MHz, MeOD) 
δ 6.55-6.53 (s, 2H), 4.72 (dd J= 18.0, 7.8, 1H, 4.08 (ddd, J= 12.9, 
6.0, 2.8, 1H), 3.04 (td, J= 12.0, 4.3, 1H), 2.76-2.70 (m, 1H), 2.66-
2.60 (m, 2H), 2.56 (dd, J= 17.9, 7.9, 1H), 2.41-2.36 (m, 1H), 1.80-
1.73 (m, 1H);  13C NMR  (151MHz,  MeOD DEPT)  C  175.9,  145.6,  
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Table 1. NMR spectroscopic data for trolline (600 MHz, MeOD). 
 
Position δC  type δH (J in Hz) HMBC
a
 
1 28.8 CH2 
1.83-1.73 m 
2.66-2.60 m 
2, 4, 10b 
2 32.7 CH2 2.56, dd (17.9,7.9) 1, 3, 4 
3 175.9 C   
4 58.3 CH 4.72, dd (18.0, 7.8) 1, 6b, 10b 
5 38.6 CH2 
4.08, ddd (12.9, 6.0, 2.8) 
3.04, td (12.0, 4.3) 
3, 4, 6, 6b 
6 28.8 CH2 
2.76-2.70 m 
2.66-2.60 m 
5, 6b, 10b 
6b 125.5 C   
7 116.2 CH 6.55-6.53 s 6, 9, 10b 
8 145.5 C   
9 145.6 C   
10 112.4 CH 6.55-6.53 s 4, 6b, 8 
10b 129.8 C   
 
a
Proton-carbon HMBC for 2-3 bond connectivity. 
 
 
 
145.5, 129.8, 125.5; CH 116.2, 112.4, 58.3; CH2 38.6, 32.7, 28.8, 
28.8; HREIMS M* 219.0882 Molecular formula C12H13NO3; Ring 
plus double bond (RDB) analysis =7. 
 
 
In vitro biological screening 
 
Anti-inflammatory assay 
 
Chemoluminiscence method as described by Helfand et al. (1982) 
was adopted. Briefly, 25 µL from each of the prepared trolline 
concentrations of 1, 10 and 100 mg/ml was incubated with 25 µL of 
diluted whole blood HBSS++ (Hanks Balanced Salt Solution, 
containing calcium chloride and magnesium chloride) [Sigma, St. 
Louis, USA]. Incubation of prepared cells and control (containing no 
test compound) was done at 37°C for 15 min in white half area 96 
well plates (Costar, NY, USA) in a luminometer thermostat chamber 
(Labsystems Helsinki, Finland). Exactly 25 µL each of opsonized 
zymosan (Fluker Buchs, Switzerland) and luminol (Research 
Organics Cleveland, USA) were added into each well except for 
blank wells containing only HBSS++. Readings indicating reactive 
oxygen species (ROS) levels were recorded in luminometer and 
expressed as relative light units (RLU). Ibuprofen was used as 
standard control anti-inflammatory drug. 
 
 
MCF-7 breast cancer cell lines MTT assay 
 
The method as described by Scudiere et al. (1988) involves 
seeding 96 well tissue culture treated flat bottom plates with 
precultured MCF-7 cell lines in Dulbecco’s modified Eagle medium 
(5% CO2 incubator at 37°C). After incubation for 24 h, 50 µM of 
trolline was added to each well in triplicate and incubated for 48 h. 
The tetrazolium salt MTT (3-(4,5-dimethylthiazol-yl)-2,5-diphenyl 
tetrazolium bromide) was added (200 µL) after washing the cells 
and then incubated for 3 h at 37°C. Formazan crystals formed were 
dissolved in 100 µL DMSO and absorbance taken at 570 nm using 
micro-plate reader (Spectra Max plus, Molecular devices, CA, 
USA). Results were recorded as percent growth inhibition of viable 
cells. Prepared alongside was doxorubicin as the control drug. 
In silico evaluation 
 
The physicochemical properties of trolline were evaluated using 
Admet predictor software, a commercially available licensed 
property of Simulations plus Inc Lancaster, USA. SMILE notations 
of isolated compound and controls used in the assays described 
was used to create the input files. Predictions were carried out on 
the 2D generated structures of the compounds using default 
settings of pH 7.4. 
 
 
RESULTS 
 
NMR assignments 
 
As presented in the spectroscopic data, the molecular 
formula as determined from HREI-MS is C12H13NO3 with 
pseudo molecular ion peak appearing at 218 m/z. The 
molecular mass was confirmed by ESI-MS with [M+H]
+
 
220 m/z. The FTIR analysis is in conformity with the odd 
numbered molecular mass suggesting the presence of N 
atom occurring as a tertiary amide functional group. NMR 
13
C (DEPT) analysis identifies presence of 12 carbons 
defined thus, 5 quartenary (1 carbonyl and 4 aromatic 
carbons), 3 methine (2 quartenary and 1 aliphatic) and 4 
aliphatic methylene carbons. Presented in Table 1 is the 
NMR assignment using 2D spectroscopic data. The 
aromatic methine protons are assigned to C7 (δ 116.2) 
and C10 (δ 112.4) in para positions due to the tall singlet 
observed in 
1
H NMR. The HMBC experiment (Table 1) 
described in the schematic (Figure 1) shows the 2-3 bond 
connectivity.  
 
 
Bioactivities 
 
Figure 2 presents the bioactive effects of trolline  on  anti- 
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Figure 1. HMBC correlations (1H - 13C) for the 
compound, trolline. 
 
 
 
 
 
Figure 2. Anti-inflammation and anti-MCF-7 proliferative effects of trolline. 
 
 
 
inflammation and growth inhibition of MCF-7 breast 
cancer cell lines. The results show IC50 of 53.8 µg/ml 
concentration on anti-inflammatory effects and 48% 
inhibition of MCF-7 cell lines proliferation at 50 µM.  
 
 
In silico predictions 
 
Predictions on solubility in different solvent systems as 
presented in Figure 3 indicate that trolline is moderately 
soluble in gastric and intestinal fluids. Prediction models 
suggest the compound to be soluble in aqueous 
environment over a pH range of 1.6 to 6.8. Models for 
permeability predictions (Figure 4) indicate 5.61 x10
-4
 
cm/s effective jejunal permeability for trolline which is 
relatively high as compared to the cytotoxic drug 
doxorubicin predicted to have <0.5 x 10
-4
 cm/s, 
suggesting a low permeability property for this 
compound.  
Plasma protein binding properties of trolline presented 
in Table 2 indicate the compound exist more in the free 
state rather than bound to plasma proteins. Trolline 
preferentially sequester within the blood rather than 
plasma (RBP = 1.25) and has minimal tissue distribution 
(as the model predicts).  
DISCUSSION 
 
The concentration of 53.8 µg/ml (0.25 mM) recorded for 
anti-inflammation could be considered significant as it 
falls within minimum concentration (IC50) of 156 to 400 
µg/ml (Choudhary et al., 2009). Inflammation is a normal 
physiologic response to disease and tissue damage. 
There are emerging evidences however, linking chronic 
inflammation and carcinogenicity (Coussens and Werb, 
2002; Coussens et al., 2013), notably the chemokine 
system and recruitment of tumor related macrophages 
(Mantovani et al., 2010). Although, 90% mortality was 
recorded for doxorubicin at 50 µM (Figure 2), non-target 
cells cytotoxicity and other contra-indications associated 
with use of doxorubicin are limitations to the use of this 
compound (Alexieva et al., 2014). Comparatively 
however, and at similar concentrations, trolline was 
observed to inhibit 48% growth of MCF-7 breast cancer 
cells. Compounds with pyrrolo[2,1-a]isoquinoline 
structure are reported to have hypotensive and anti-tumor 
activities (Mikhailovskii and Shklyaev, 1997) as well as 
antibacterial properties (Wang et al., 2004). Oleracein E 
(the antipode of trolline) has been reported to exhibit 
potent DPPH radical scavenging activity (Yang et al., 
2009). Other cytotoxic compounds characterized from  M.  
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Figure 3. Prediction models on compound solubility. Sw = native 
solubility in water; FasGF = solubility in simulated fasted state gastric 
fluid; FasIF = solubility in simulated fasted state intestinal fluid; FeSIF = 
solubility in simulated fed state intestinal fluid; Simulations Plus. 
 
 
 
 
 
Figure 4. Prediction models on jejunal permeability. S+logP = octanol-
water partition coefficient; s+Peff = human jejunal effective permeability.  
 
 
 
Table 2. Predictions on protein binding, volume of 
distribution and blood-plasma concentrations. 
 
Compound  PrUnbnd (%) VD (L/Kg) RPB 
Trolline 60.23 0.95 1.25 
Ibuprofen 2.10 0.34 0.58 
Doxorubicin 21.56 11.48 0.99 
 
PrUnbnd: % unbound proteins; VD: volume of distribution; 
RPB: blood-plasma ratio. 
 
 
 
jalapa, notably the cytotoxic rotenoids mirabijalones and 
boeravinones have been shown to have growth  inhibition 
effects against several cell lines (Wang et al., 2002; Xu et 
al., 2010).  
Predictions on absorption properties for trolline 
conforms with laboratory findings using human Caco-2 
cell monolayer model (Li-Jia et al., 2014), suggesting 
trolline to be moderately absorbed in the GIT. Similar 
trends in prediction results were observed for ibuprofen 
used as control for anti-inflammation properties; shown to 
be highly lipophilic and permeable to the jejunum (Figure 
4) but relatively low in solubility (Figure 3). Ibuprofen 
traversing the GIT is a pH dependent phenomenon, 
permeable through walls of the stomach but not readily 
soluble; thus, limiting its entry into systemic circulation 
(Patel et al., 2011).  
788          J. Med. Plants Res. 
 
 
 
Table 3. Predictions on compound LD50 and TD50 in rats. 
 
Compound LD50 (mg/Kg) TD50 (mg/Kg/day) 
Trolline 950.00 107.23 
Ibuprofen 1175.37 82.27 
Doxorubicin 463.14 19.17 
 
LD50 = LD50 for lethal rat acute toxicity; TD50 = TD50, defined as 
the oral dose of a compound required to induce tumors in 50% of a 
rat population after exposure over a standard lifetime. 
 
 
 
Key parameters for drugs intended for oral administration 
are solubility and permeability.  Dissolution of target drug 
dose around site of absorption increases the propensity 
for bioavailability (Amidon et al., 1995). Thus, early 
identification of low solubility drug candidates estimated 
at 40% of new drugs (Dahan and Muller, 2012) is 
important in the long term downstream screening. High 
jejunal permeability was predicted for trolline and was 
also shown to be present in blood more in the free state 
rather than bound to plasma proteins. Model prediction 
on the control drug doxorubicin (Table 2) however 
indicates high volume of tissue distribution, which is 
consistent with literature reports (809-1214 Lm
-2
) on the 
pharmacokinetics of doxorubicin with a distribution half-
life of 5 min (National Center for Biotechnology 
Information, 2016).  
Existence of drugs in free unbound state allows for 
effective interactions with target receptors thus increasing 
drug efficacy. Alterations in plasma protein binding 
inevitably affect dose formulations, clearance time and 
systemic distribution of drugs (Scheife, 1989; Roberts et 
al., 2013). The quantitative structure activity relationships 
(QSAR) methods used in developing descriptors for in-
silico predictions provide insights into the probable 
behaviour of NCEs with plasma proteins (Saiakhov et al., 
2000; Ghafourian and Amin, 2013). 
Communities, especially in developing countries where 
use of medicinal plant is a common cultural practice, 
these plants are often not regarded as food but are 
however consumed at concentrations exceeding what is 
obtainable in clinical practice. Predictions (Table 3) on 
lethal rat acute toxicity (LD50) observed for trolline was 
950 mg/kg; and a life time oral dose administration (TD50) 
of 107.23 mg/kg/day is likely to induce tumors (in rats). 
Considering standard practice in drug dosage 
formulations, we assume from predicted values as well 
as moderate toxicity against MCF-7 breast cancer cells 
(in vitro), trolline may not constitute a threat to normal 
body homeostasis but construed to play functional roles 
in the long term prevention of early onset of disease and 
other forms of tissue damage. However, this is a subject 
matter for clinical verification. In silico predictions on 
administration, distribution, metabolism and elimination 
(ADME) of drugs in modern day research has the 
advantage of limiting time and reducing the cost of 
searching for NCEs with drug-like potentials (Butina et 
 
 
 
 
al., 2002; Kapetanovic, 2008). 
 
 
Conclusion 
 
In silico simulation and prediction are becoming more 
efficient and fast gaining popularity and robust 
applicability in pharmaceutical research. The 
development of proficient machine language 
programming has revolutionalized this tool as a 
necessary cost effective step in drug discovery. The 
compound, trolline was demonstrated to have clinically 
important bioactive properties and predictions on the 
physico-chemical properties of this compound are quite 
promising in terms of its characteristic drug like 
properties. 
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